Tuesday, June 18, 2019

Konstantinos Syrigos

MD, PhD, FCCP, Professor of Medicine & Medical Oncology, Head, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, National & Kapodistrian University, Adj. Professor of Medicine, Pittsburgh School of Medicine, USA, Vis. Professor of Thoracic Oncology, Yale School of Medicine, USA

Konstantinos Syrigos
Konstantinos Syrigos

Professor Kostas Syrigos graduated from Athens School of Medicine in 1988. He was trained in Internal Medicine at the Laikon University Hospital (Athens University) and in Medical Oncology at the Hammersmith Hospital (Imperial College of Medicine, Sciences & Art, London University). He got his MD thesis with distinction from the Athens School of Medicine, in 1995 and his PhD thesis from the Imperial College of Science, Technology and Medicine, London University, in 2000.

He worked as Medical Oncologist Senior Registrar at the Hammersmith and St Bartholomew’s Hospitals, in London and as consultant at the Sotiria General Hospital, in Athens. In 2002 he was appointed Assc. Professor of Oncology in Medicine and Head of the Sotiria Oncology Unit. From 2006 he is also Visiting Professor of Thoracic Oncology at Yale University and from 2012 he is also Adjunct Professor of Medicine at Pittsburgh School of Medicine, USA. His main fields of interest are Targeted Therapies, drugs development as well as Thoracic and Head & Neck oncology. Recently (2014) he was appointed Head of the 3rd Department of Medicine, Athens School of Medicine at “Sotiria” General Hospital.

Dr Syrigos participated in several international clinical trials Phase I-IV in lung, colon, head & neck and pancreatic cancer. He is a member of numerous scientific societies, including the European Society of Medical Oncology (ESMO), the European Respiratory Society (ERS), the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), the American College of Chest Physicians (ACCP) and the International Association for the Study of Lung Cancer (IASLC).

He is co-editor of the Oncology Research journal, on the editorial board of 21 scientific journals and reviewer for 90 scientific journals. He is the editor of 14 International Scientific Volumes. He is the author of 430 peer-reviewed, international articles, with more than 6.000 citations. He is currently sitting as member of the ESMO Translational Research Group, as member of the IASLC Education Committee and as ESMO faculty member for the Lung and other Thoracic Tumours faculty group.

Keynote Speakers

A. John Iafrate Dr. Iafrate is a Professor of Pathology at Harvard Medical School and is Director of the Center for Integrated Diagnostics (CID), a clinical laboratory for molecular diagnostics and newly appointed Vice Chair of Academic Affairs at the Massachusetts General Hospital (MGH).
Stephen Palmer Stephen Palmer is a Professor and Deputy Director of TEEHTA. He has worked in economic evaluation for over 15 years in areas including pharmaceuticals, cardiology, cancer, mental health, diagnostic and screening programmes and policy. He has extensive experience of health economic evaluation, regulatory and reimbursement processes.
Luca Sangiorgi He is Head of Department of Medical Genetics and Coordinator of Rare Disease Centre at Rizzoli Orthopaedic Institute, Bologna, and Contract professor of Clinical Genetics of Bologna University.

© 2019 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team